Previous 10 | Next 10 |
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) on behalf of Talis stockholders. Our investigation conce...
Gainers: Regional Health Properties (NYSE:RHE) +55%. AC Immune (NASDAQ:ACIU) +34%. Net Element (NASDAQ:NETE) +27%. Vallon Pharmaceuticals (NASDAQ:VLON) +25%. Spok (NASDAQ:SPOK) +23%. Elys Game Technology (NASDAQ:ELYS) +21%. Youdao (NYSE:DAO) +20%. Qualigen Therapeutics (NASDAQ:QLGN) +18%. Azu...
Gainers: Regional Health Properties (NYSE:RHE) +53%, AC Immune (NASDAQ:ACIU) +39%, Regencell Bioscience (NASDAQ:RGC) +29%, Qualigen Therapeutics (NASDAQ:QLGN) +19%, Reneo Pharmaceuticals (NASDAQ:RPHM) +17%. Losers: RenovoRx (NASDAQ:RNXT) -21%, ...
MENLO PARK, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that effective immediately Brian Coe has stepped down as P...
Image source: The Motley Fool. Talis Biomedical (NASDAQ: TLIS) Q2 2021 Earnings Call Aug 10, 2021 , 4:30 p.m. ET Continue reading For further details see: Talis Biomedical (TLIS) Q2 2021 Earnings Call Transcript
Talis Biomedical Corporation (TLIS) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET Company Participants Emily Faucette – Senior Vice President-Corporate Communications and Investor Relations Brian Coe – Chief Executive Officer Doug Liu – Chief Operating Offic...
Talis Biomedical (NASDAQ:TLIS): Q2 GAAP EPS of -$2.51 misses by $1.64. Revenue of $0.1M Shares +1.7%. Press Release For further details see: Talis Biomedical EPS misses by $1.64
MENLO PARK, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today reported financial results and business progress for the second quar...
You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)
MENLO PARK, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the second quarter af...
News, Short Squeeze, Breakout and More Instantly...
Talis Biomedical Corporation Company Name:
TLIS Stock Symbol:
NASDAQ Market:
Talis Biomedical Corporation Website:
2024-07-14 22:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-24 12:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...